🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This research study is evaluating the safety and efficacy of a combination ...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2020-07-20
Trial ID
NCT04290546
Treatments Being Tested
Reducing HIV persistence in lymph nodes by Interleukin-15 (IL-15) Receptor ...
Status
Active Not Recruiting
Location
Thai Red Cross AIDS Research Centre
Start Date
2021-03-01
Trial ID
NCT04505501
Treatments Being Tested
This early phase I trial tests the safety and how well N-803 works in treat...
Status
Recruiting
Location
Northwestern University
Start Date
2026-04-13
Trial ID
NCT07261657
This is a phase I, randomized, open-label trial to investigate the safety o...
Status
Withdrawn
Location
Thai Red Cross AIDS Research Centre (TRCARC)
Start Date
2023-09-01
Trial ID
NCT05769569
This study will test the safety and tolerability of Anktiva in patients wit...
Status
Recruiting
Location
University of California - San Francisco
Start Date
2025-11-14
Trial ID
NCT07108036
Treatments Being Tested
This is a phase 1b/2 study to evaluate the safety and efficacy of metronomi...
Status
Terminated
Location
Chan Soon-Shiong Institute for Medicine
Start Date
2018-01-09
Trial ID
NCT03387111
This phase II/III Lung-MAP trial studies how well immunotherapy treatment w...
Status
Active Not Recruiting
Location
Veterans Administration Medical Center - Birmingham
Start Date
2022-03-15
Trial ID
NCT05096663
Phase 2, single-arm study to evaluate combination therapy of avelumab, haNK...
Status
Terminated
Location
University of California San Francisco
Start Date
2020-02-19
Trial ID
NCT03853317
Open-label, Phase 1 Study of CD19 t-haNK as a Single Agent and in Combinati...
Status
Recruiting
Location
Hoag Memorial Hospital
Start Date
2025-08-22
Trial ID
NCT05618925
Treatments Being Tested